Basic info
Industry
biotechnology research
Sectors
antibody therapeutics
ADC
Biotechnology
effector function modulation
Breast Cancer
protein engineering
Biliary Tract Cancer
Therapeutics
Gastric Cancer
Medical
Immune redirection
bispecific antibodies
Date founded
2003
Funding rounds raised
Total raised
$98M
from 11 investors over 11 rounds
Z
Zymeworks Inc. raised undisclosed on November 6, 2019
Investors: Amplitude Ventures
Z
Zymeworks Inc. raised $98M on June 8, 2018
Investors: Paradigm Capital, MTS Health Partners and Raymond James
Z
Zymeworks Inc. raised $62M on January 8, 2016
Investors: Merlin Nexus, Lumira Ventures, Brace Pharma Capital, Teralys Capital, Perceptive Advisors, Northleaf Capital Partners and Celgene